title: Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.
abstract: There is a growing interest in the role that cancer biomarkers, metastasis-related molecules, and chemokines may play in the development and progression of various cancers. However, few studies have addressed the reliability of such biomarkers in healthy individuals over time. The objective of this study was to investigate the temporal reliability of multiple proteins in serum samples from healthy women who donated blood over successive years. Thirty five, postmenopausal women with two, repeated annual visits, and thirty, premenopausal women with three, repeated annual visits were randomly selected among eligible subjects from an existing, prospective cohort. Multiplexing Luminex xMAPTM technology was used to measure the levels of 55 serum proteins representing cancer antigens, chemokines, angiogenic and anti-angiogenic factors, proteases, adipokines, apoptotic molecules, and other markers in these women. The biomarkers with high detection rates (> 60%) and acceptable reliability (intraclass correlation coefficient, ICCs > or = 0.55) using xMAPTM method were: cancer antigens: AFP, CA 15-3, CEA, CA-125, SCC, SAA; growth factors/related molecules: ErbB2, IGFBP-1; proteases and adhesion molecules: MMP-1, 8, 9, sE-selectin, human kallikreins (KLK) 8,10, ICAM-1, VCAM-1, chemokines: fractalkine, MCP-1,2, RANTES, MIP-1alpha, MIP-1beta, Eotaxin, GRO-alpha, IP-10; inhibitors of angiogenesis: angiostatin and endostatin; adipokines leptin and resistin; apoptotic factor: Fas, and other proteins mesothelin, myeloperoxidase (MPO), and PAI-1. The rest of the biomarkers under investigation either had ICCs less than 0.55 or had low levels of detection (< 60%). These included cancer antigens: CA 19-9, CA 72-4, MICA, S100, TTR, ULBP1, ULBP2, ULBP3; proteases: MMP 2, 3, 7, 12, 13; chemokines: MCP-3, MIF, MIG; adipokines: leptin and resistin; apoptotic factors: FasL, DR5, Cyfra 21-1; and inhibitors of angiogenesis and other markers: thrombospondin and heat shock protein (HSP) 27. In conclusion, 34 out of the 55 biomarkers investigated were present in detectable levels in > 60% of the samples, and with an ICC > or = 0.55, indicating that a single serum measurement can be used in prospective epidemiological studies using the xMAPTM method.
authors.affiliation: University of Pittsburgh Cancer Institute, Division of Cancer Prevention and Population Science, 5150 Centre Ave, Room 466, Pittsburgh, PA 15224, USA. fyL1@pitt.edu
authors.forename: Faina
authors.initials: F
authors.lastname: Linkov
authors.forename: Yian
authors.initials: Y
authors.lastname: Gu
authors.forename: Alan A
authors.initials: AA
authors.lastname: Arslan
authors.forename: Mengling
authors.initials: M
authors.lastname: Liu
authors.forename: Roy E
authors.initials: RE
authors.lastname: Shore
authors.forename: Lyudmila
authors.initials: L
authors.lastname: Velikokhatnaya
authors.forename: Karen L
authors.initials: KL
authors.lastname: Koenig
authors.forename: Paolo
authors.initials: P
authors.lastname: Toniolo
authors.forename: Adele
authors.initials: A
authors.lastname: Marrangoni
authors.forename: Zoya
authors.initials: Z
authors.lastname: Yurkovetsky
authors.forename: Anne
authors.initials: A
authors.lastname: Zeleniuch-Jacquotte
authors.forename: Anna E
authors.initials: AE
authors.lastname: Lokshin